On Friday, Jan. 7, the U.S. Supreme Court will hold nearly unprecedented oral arguments on whether to allow the Centers for Medicare & Medicaid Services’ and Occupational Safety and Health Administration’s vaccine mandates to go into effect while appeals are heard in the courts of appeals. “It is nearly unprecedented for the Court to hear argument at the stay — rather than the merits — stage, as they are doing here, and typically there would have been more briefing on issues of such significance,” writes Sean Marotta, a partner at Hogan Lovells and AHA outside counsel, in a new blog post. “And because these particular mandates are time-limited — by statute, the OSHA mandate can last only six months and the CMS mandate will likely last for a similar period — the Supreme Court’s stay decision may effectively decide whether these mandates go into effect at all, depending on how quickly the Court issues its decisions.” 

View today’s full blog post breaking down the legal issues confronting the Court and what to look for when the Justices hear the oral arguments. On Friday, watch for more analysis from Marotta on AHA’s blog page as well as a new podcast. 
 


Related News Articles

Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…
Headline
Fewer than one in four health care professionals working in acute care hospitals and nursing homes were up to date with COVID-19 vaccination during the 2022-23…
Headline
Children under age 12 should receive a 0.25 milliliter dose of the 2023-24 Moderna COVID-19 vaccine, not the full vial for that age group, the Food and Drug…